FRONTLINE/ CY0200352116 /
2024-05-24 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
304.40NOK | - | 495,932 Turnover: - |
-Bid Size: - | -Ask Size: - | 67.63 bill.NOK | - | - |
GlobeNewswire
7:00 AM
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
GlobeNewswire
05-24
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
GlobeNewswire
05-23
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire
05-23
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
05-21
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Ph...
GlobeNewswire
05-20
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
GlobeNewswire
05-20
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for it...
GlobeNewswire
05-16
Harri Announces Product Innovation Designed to Propel the Frontline Employee Experience and Restaura...
GlobeNewswire
05-16
Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million
GlobeNewswire
05-14
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-17215...
GlobeNewswire
05-14
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire
05-13
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire
05-09
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire
05-08
HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with...
GlobeNewswire
05-06
Inteleos to Host Roundtable on Advancing Maternal Health through Point-Of-Care-Ultrasound Certificat...